Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

NCT05863936 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Lupus Nephritis
Remission
Safety Issues

Interventions

DRUG: Methylprednisolone Injectable Suspension
DRUG: Belimumab Injection
DRUG: Immunosuppressive Agents

Sponsor

Nanjing University School of Medicine